Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Agomelatine for obsessive-compulsive disorder
2009-016713-20Phase 2Completed
- Sponsor
- Servier
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in obsessive compulsive disorder (OCD) comparing Agomelatine with Placebo (2 arms). Primary endpoint: Yale-Brown Obsessive Compulsive Scale. Started Feb 2010; status: completed.
02
Drugs
agomelatine
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on 2009-016713-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016713-20.